Interim data from Phase I dose-escalation study of mRNA cancer Immunotherapy (mRNA-4359) has shown promise in patients with advanced solid tumors. The investigational mRNA cancer immunotherapy...
Interim data from Phase I dose-escalation study of mRNA cancer Immunotherapy (mRNA-4359) has shown promise in patients with advanced solid tumors. The investigational mRNA cancer immunotherapy...
Authors on the study included, from left, Jennifer Pietenpol, PhD, Melinda Sanders, MD, Brian Lehmann, PhD, Vandana Abramson, MD, and Yu Shyr, PhD. (photo by Donn...
The Advanced Research Projects Agency for Health (ARPA-H) has awarded $45 million to rapidly develop sense-and-respond implant technology that could slash U.S. cancer-related deaths by more...
In a recent study published in communication biologyResearchers evaluated the therapeutic effects of naboximod in combination with herpes simplex 1 (HSV-1) viral therapy for hepatocellular carcinoma...
A research team from the LKS School of Medicine at the University of Hong Kong School of Medicine (HKUMed) has identified an unexpected factor in cancer...
Recent Comments